Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

HMG-17 Inhibitors

The chemical class known as HMG-17 inhibitors comprises a diverse range of compounds designed to modulate the activity of HMG-17, a member of the high-mobility group (HMG) family of proteins. These proteins play integral roles in chromatin structure, gene expression, and other nuclear processes. HMG-17, in particular, has been implicated in various cellular functions due to its ability to bind to DNA and influence chromatin organization. HMG-17 inhibitors are characterized by their capability to interact with specific regions or domains of HMG-17, effectively disrupting its DNA-binding activity and altering its influence on chromatin architecture and gene regulation. Structurally, HMG-17 inhibitors encompass a broad spectrum of chemical entities, including natural compounds and synthetic molecules. These inhibitors are designed with careful consideration of the binding interfaces and interaction sites of HMG-17 involved in DNA recognition. Often, they feature chemical groups that facilitate interactions with key residues in the DNA-binding region of HMG-17. By effectively binding to this protein, these inhibitors aim to prevent or weaken its affinity for DNA, thereby impacting the functional roles of HMG-17 in gene expression and chromatin dynamics.

The development of HMG-17 inhibitors involves a multidisciplinary approach, combining computational modeling, structural biology, and chemical synthesis. Researchers work to optimize the chemical structures of these compounds, aiming to enhance their binding affinity, specificity, and overall inhibitory potency against HMG-17. Iterative design and testing are critical in refining these inhibitors to achieve the desired modulation of HMG-17 activity. Upon synthesis, HMG-17 inhibitors undergo rigorous biochemical characterization and cellular studies to validate their inhibitory effects. These studies often involve assessing changes in DNA-HMG-17 interactions, chromatin structure, and downstream gene expression patterns upon HMG-17 inhibition. By elucidating the impact of HMG-17 inhibition on cellular processes, researchers gain insights into the roles of this protein in fundamental biological mechanisms.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine has been studied for its ability to inhibit the DNA-binding activity of HMG-17, potentially affecting chromatin organization and gene expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin, a natural compound found in turmeric, has been suggested to have inhibitory effects on HMG-17, potentially influencing its role in chromatin structure and gene expression.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin, a flavonoid abundant in many plant-based foods, has been studied for its potential to modulate the interaction between HMG-17 and DNA.

Rutin trihydrate

250249-75-3sc-204897
sc-204897A
sc-204897B
5 g
50 g
100 g
$57.00
$72.00
$126.00
7
(1)

Rutin, another flavonoid, has been investigated for its ability to affect HMG-17's DNA-binding activity, potentially altering its role in chromatin organization.

Caffeic Acid

331-39-5sc-200499
sc-200499A
1 g
5 g
$32.00
$62.00
1
(2)

Caffeic acid, a phenolic compound found in various plants, has been studied for its effects on HMG-17's DNA-binding properties.